🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎉 Herzlichen Glückwunsch zum 60. Geburtstag! Unser DZD-Partner, das Deutsches Diabetes-Zentrum, feiert heute sein 60jähriges Bestehen. Seit 1964 leistet das DDZ herausragende Arbeit in der #Diabetesforschung + verbessert die Lebensqualität von Menschen mit #Diabetes.

About to kick off the Deutsche Zentren der Gesundheitsforschung (DZG) day hosted by @Leibniz_DIfE! Come for the #science and stay for the #CareerTips! Grateful for the amazing support of #research by the Bildungsmisererepublik Deutschland - BRDigung!

#WDD. Ergebnisse aus der Forschung möglichst schnell vom Labor zu den Menschen zu bringen, um #Diabetes besser vorzubeugen und präziser zu behandeln, dass ist die Aufgabe des DZD. Am #WeltdiabetesTag stellen wir einige Forschungserfolge des DZD vor. ➡️dzd-ev.de/forschung/tran…

Today’s the day! 🎉 We’re in front of Caruso for #WorldDiabetesDay until 2 PM. Stop by to learn about diabetes prevention and see the work we’re doing here at the PLID. See you soon! 💙 #DiabetesAwareness

Früherkennung von Typ-1-Diabetes in die Regelversorgung! 👉 Zum #Interview mit Prof. Anette-Gabriele Ziegler: t1p.de/r7c6m #Typ1Diabetes ist die häufigste #Stoffwechselerkrankung bei #Kindern – und die steigenden Diagnosen sind alarmierend. Oft wird die Krankheit zu

New study indicates that the transcriptional heterogeneity of non-beta cells has an impact on intra-islet crosstalk and participates in beta cell (dys)function @Leibniz_DIfE Thilo Speckmann Prateek Chawla, PhD Heiko Lickert #Islets #DiabetesResearch tinyurl.com/3y7nr3tu🔓

Congratulations to Pascal, Thilo, Annette and team for this very interesting study describing the impact of non-beta cells on beta cell function and failure. Would not have been possible without our great support from and interactions within the DZD Deutsches Zentrum für Diabetesforschung (DZD)

Congratulations 🎇🎀🥂 on your big success!

Join us for our next #ExternalDiabetesSeminar on single-cell & spatial proteomics! Marvin Thielert from the Matthias Mann Lab at Max Planck Institute of Biochemistry (MPIB) will speak on Nov 26 at 3pm. Learn about the latest advancements in translational medicine & pancreatic islet biology! t1p.de/l3a6v

🎙 The future of #diabetes care is here!🌍 Professors Annette Ziegler & Matthias Blüher discuss groundbreaking advancements in #Type1Diabetes & #type2diabetes therapies, vaccines, and more. 🎧 Listen now: easd.org/media-centre/p… #FutureofMedicine #MetabolicMedicine #EASD2024

„In 2022, an estimated 828 million adults had diabetes, an increase of 630 million from 1990.“ This is why we need research on #diabetes and #prevention! Deutsches Zentrum für Diabetesforschung (DZD) Worldwide trends in diabetes prevalence and treatment from 1990 to 2022- The Lancet thelancet.com/journals/lance…

New Approach for Diabetes Therapies: Inceptor Regulates Insulin Homeostasis 👉t1p.de/i4a7a Scientists led by Prof. Heiko Lickert at #HelmholtzMunich have uncovered a new role for #Inceptor, a receptor regulating #insulin homeostasis. 💡Blocking Inceptor could boost

Ever wondered why processed foods might be so unhealthy? It’s more than just calories. Turns out carrageenan, a common food additive, can make your gut leaky. And also more... Read about our study we did with Norbert Stefan and others Deutsches Zentrum für Diabetesforschung (DZD) link.springer.com/article/10.118…

Mit diesem Post verabschiedet sich der idw von seinem X-Kanal. PM unserer Mitglieder werden weiterhin über X verbreitet: x.com/idw_online_de Mitglieder, die ihre PM nicht mehr über X verteilen möchten, können sich per Mail an [email protected] abmelden!

It's time to say goodbye to this platform.👋 Thank you for following us and interacting with us here! Let's stay connected on LinkedIn linkedin.com/company/german…, visit our website bbmri.de for updates, and subscribe to our newsletter bbmri.de/service/newsle… #biobank

A future without needles - news and views together with Vasilis Ntziachristos . Here is the free read only article rdcu.be/d8HKR MunichImaging Helmholtz Munich | @HelmholtzMunich Uniklinikum Tübingen Deutsches Zentrum für Diabetesforschung (DZD)

Diabetes poses a significant global burden, with an escalating incidence, particularly in low- and middle-income communities. We discribe how prediabetes remission to normal glucose regulation helps to reduce global burden of T2D. Uniklinikum Tübingen Helmholtz Munich | @HelmholtzMunich Deutsches Zentrum für Diabetesforschung (DZD)

New Study Reveals Key to How Pancreatic Insulin-Producing Beta Cells Are Formed🔬 👉t1p.de/7rivd A team led by Prof. Henrik Semb, #HelmholtzMunich, has uncovered how immature pancreatic cells decide whether to become insulin-producing beta cells or glucagon-producing

GIP Receptor – Activation and Blockade Support Weight Loss 🧬 👉t1p.de/ovdzo New insights from #HelmholtzMunich, the German Center for Diabetes Research, and Ludwig-Maximilians-Universität München reveal that both activating and blocking the GIP receptor can lead to

Congratulations to Martin Schön Martin Schön for the Prevention Prize of the German Society of Internal Medicine. May the 4th be with you, and may your research prevent #diabetes complications. #DGIM Deutsches Zentrum für Diabetesforschung (DZD)